Symmetry Medical Inc (SMA) 9.27 $SMA
Hutchison up 20.1% following OIS actuator deal
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 10:30AM CST
SMA: 9.27 (-0.04), HTCH: 3.71 (+0.09)
Symmetry Medical Divests OEM, Surgical Goes Public - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 12:40PM CST
Symmetry Medical Inc. (SMA) recently completed the divestiture of its OEM solutions business unit to Tecomet Inc.
SMA: 9.27 (-0.04), IART: 56.89 (+0.62), MDT: 75.26 (+0.33), CFN: 59.81 (+0.01)
Tecomet concludes OEM Solutions Business' acquisition
M2 - Mon Dec 08, 5:56AM CST
Medical device company Tecomet reported on Friday the completion of the acquisition of the OEM Solutions business from Symmetry Medical (NYSE:SMA) for an undisclosed amount.
SMA: 9.27 (-0.04)
Symmetry Medical Completes Sale of Its OEM Solutions Business and Separation of Symmetry Surgical Inc.
GlobeNewswire - Fri Dec 05, 12:35PM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it has completed the merger that gives effect to the sale of Symmetry Medical's OEM Solutions business to affiliates of Tecomet Inc. and the concurrent transfer to the Symmetry Medical stockholders of ownership in a new company holding the Symmetry Surgical business, Symmetry Surgical Inc. Shares of Symmetry Surgical Inc. will begin trading on the NASDAQ under the symbol "SSRG." Trading of Symmetry Medical Inc. shares on the New York Stock Exchange ceased trading as of today and will be delisted.
SMA: 9.27 (-0.04), SSRG: 7.50 (-0.08)
Tecomet, Inc. Acquires Symmetry Medical OEM Solutions Business
PR Newswire - Fri Dec 05, 12:35PM CST
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's (NYSE: SMA) OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
SMA: 9.27 (-0.04)
Health Care Equipment Stocks Technical Analysis - Boston Scientific, Becton Dickinson, St. Jude Medical, Accuray, and Symmetry Medical
PR Newswire - Fri Dec 05, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Becton Dickinson and Company (NYSE: BDX), St Jude Medical Inc. (NYSE: STJ), Accuray Inc. (NASDAQ: ARAY), and Symmetry Medical Inc. (NYSE: SMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 04, 2014, the NASDAQ Composite ended at 4,769.44, down 0.11%, the Dow Jones Industrial Average edged 0.07% lower, to finish the day at 17,900.10, and the S&P 500 closed at 2,071.92, down 0.12%. The losses were broad based as seven out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 811.12, down 0.12%, while the index has advanced 10.05% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 14.98 (+0.24), SMA: 9.27 (-0.04), BDX: 143.71 (+0.72), STJ: 67.48 (+0.65), ARAY: 8.00 (+0.24)
Symmetry Medical Stockholders Approve Sale of Its OEM Solutions Business and Separation of Symmetry Surgical Inc.
GlobeNewswire - Thu Dec 04, 10:09AM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, today held a special stockholder meeting at which:
SMA: 9.27 (-0.04)
Western Refining and California Resources Set to Join the S&P MidCap 400; Rayonier Advanced Materials to Join the S&P SmallCap 600
PR Newswire - Thu Nov 20, 6:13PM CST
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
SMA: 9.27 (-0.04), SGMS: 14.15 (+0.36), RYAM: 17.58 (+0.36), WNR: 40.81 (+0.47), BYI: 83.27 (unch), MHFI: 102.19 (unch), OXY: 83.11 (+1.07)
Symmetry Medical to Present at the 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Thu Nov 20, 3:30PM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to participate in a fireside chat presentation at the 26th Annual Piper Jaffray Healthcare Conference in New York, NY.
SMA: 9.27 (-0.04)
Span-America to Nominate Thomas J. Sullivan to Board of Directors
Business Wire - Tue Nov 18, 10:40AM CST
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that Thomas J. Sullivan will be nominated for election to the Board of Directors at the Company's next annual meeting, which is expected to be held in February, 2015. Mr. Sullivan currently serves as President, CEO and Director of Symmetry Medical Inc. (NYSE: SMA).
SMA: 9.27 (-0.04), SPAN: 18.30 (-0.15)
Symmetry Medical to Present at the Stifel 2014 Healthcare Conference
GlobeNewswire - Mon Nov 17, 8:29AM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to present at the Stifel 2014 Healthcare Conference in New York, NY.
SMA: 9.27 (-0.04)
Update: Symmetry Medical Posted Ordinary Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Sun Nov 09, 1:00AM CST
SMA: 9.27 (-0.04)
Symmetry Medical Q3 Earnings & Revenues Miss, Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:10PM CST
Symmetry Medical Inc. (SMA) reported adjusted earnings per share of 11 cents in the third quarter of fiscal 2014, which missed the Zacks Consensus Estimates of 14 cents.
SMA: 9.27 (-0.04), CYNO: 31.37 (+0.80), FLDM: 37.93 (-0.47), ANGO: 18.78 (+0.18)
Symmetry Medical Announces Mailing of Definitive Proxy Statement and Prospectus Related to Proposed Merger
GlobeNewswire - Wed Nov 05, 6:47AM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it is mailing the definitive proxy statement and prospectus regarding its agreement to sell its OEM Solutions business and concurrently transfer to its shareholders ownership in a new company holding its Symmetry Surgical business, Symmetry Surgical Inc. The Company will hold a special shareholder meeting on December 4, 2014, to approve the proposed transaction.
SMA: 9.27 (-0.04)
Symmetry Medical's (SMA) CEO Thomas Sullivan on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:50PM CDT
SMA: 9.27 (-0.04)
Symmetry Medical posts 3Q profit
Automated Insights - Thu Oct 30, 8:27AM CDT
WARSAW, Ind. (AP) _ Symmetry Medical Inc. (SMA) on Thursday reported profit of $1.3 million in its third quarter.
SMA: 9.27 (-0.04)
Symmetry Medical (SMA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:55AM CDT
SMA: 9.27 (-0.04)
Symmetry Medical misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:51AM CDT
SMA: 9.27 (-0.04)
Symmetry Medical Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Oct 30, 6:10AM CDT
Third Quarter Highlights:
SMA: 9.27 (-0.04)
Symmetry Medical Shares Up 12.9% Since SmarTrend's Buy Recommendation (SMA)
Comtex SmarTrend(R) - Wed Oct 29, 5:05PM CDT
SmarTrend identified an Uptrend for Symmetry Medical (NYSE:SMA) on May 29th, 2014 at $8.92. In approximately 5 months, Symmetry Medical has returned 12.89% as of today's recent price of $10.07.
SMA: 9.27 (-0.04)
Hutchison up 20.1% following OIS actuator deal
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 10:30AM CST
SMA: 9.27 (-0.04), HTCH: 3.71 (+0.09)
Symmetry Medical Divests OEM, Surgical Goes Public - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 12:40PM CST
Symmetry Medical Inc. (SMA) recently completed the divestiture of its OEM solutions business unit to Tecomet Inc.
SMA: 9.27 (-0.04), IART: 56.89 (+0.62), MDT: 75.26 (+0.33), CFN: 59.81 (+0.01)
Tecomet concludes OEM Solutions Business' acquisition
M2 - Mon Dec 08, 5:56AM CST
Medical device company Tecomet reported on Friday the completion of the acquisition of the OEM Solutions business from Symmetry Medical (NYSE:SMA) for an undisclosed amount.
SMA: 9.27 (-0.04)
Symmetry Medical Completes Sale of Its OEM Solutions Business and Separation of Symmetry Surgical Inc.
GlobeNewswire - Fri Dec 05, 12:35PM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it has completed the merger that gives effect to the sale of Symmetry Medical's OEM Solutions business to affiliates of Tecomet Inc. and the concurrent transfer to the Symmetry Medical stockholders of ownership in a new company holding the Symmetry Surgical business, Symmetry Surgical Inc. Shares of Symmetry Surgical Inc. will begin trading on the NASDAQ under the symbol "SSRG." Trading of Symmetry Medical Inc. shares on the New York Stock Exchange ceased trading as of today and will be delisted.
SMA: 9.27 (-0.04), SSRG: 7.50 (-0.08)
Tecomet, Inc. Acquires Symmetry Medical OEM Solutions Business
PR Newswire - Fri Dec 05, 12:35PM CST
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's (NYSE: SMA) OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
SMA: 9.27 (-0.04)
Health Care Equipment Stocks Technical Analysis - Boston Scientific, Becton Dickinson, St. Jude Medical, Accuray, and Symmetry Medical
PR Newswire - Fri Dec 05, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Becton Dickinson and Company (NYSE: BDX), St Jude Medical Inc. (NYSE: STJ), Accuray Inc. (NASDAQ: ARAY), and Symmetry Medical Inc. (NYSE: SMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 04, 2014, the NASDAQ Composite ended at 4,769.44, down 0.11%, the Dow Jones Industrial Average edged 0.07% lower, to finish the day at 17,900.10, and the S&P 500 closed at 2,071.92, down 0.12%. The losses were broad based as seven out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 811.12, down 0.12%, while the index has advanced 10.05% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 14.98 (+0.24), SMA: 9.27 (-0.04), BDX: 143.71 (+0.72), STJ: 67.48 (+0.65), ARAY: 8.00 (+0.24)
Symmetry Medical Stockholders Approve Sale of Its OEM Solutions Business and Separation of Symmetry Surgical Inc.
GlobeNewswire - Thu Dec 04, 10:09AM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, today held a special stockholder meeting at which:
SMA: 9.27 (-0.04)
Western Refining and California Resources Set to Join the S&P MidCap 400; Rayonier Advanced Materials to Join the S&P SmallCap 600
PR Newswire - Thu Nov 20, 6:13PM CST
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
SMA: 9.27 (-0.04), SGMS: 14.15 (+0.36), RYAM: 17.58 (+0.36), WNR: 40.81 (+0.47), BYI: 83.27 (unch), MHFI: 102.19 (unch), OXY: 83.11 (+1.07)
Symmetry Medical to Present at the 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Thu Nov 20, 3:30PM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to participate in a fireside chat presentation at the 26th Annual Piper Jaffray Healthcare Conference in New York, NY.
SMA: 9.27 (-0.04)
Span-America to Nominate Thomas J. Sullivan to Board of Directors
Business Wire - Tue Nov 18, 10:40AM CST
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that Thomas J. Sullivan will be nominated for election to the Board of Directors at the Company's next annual meeting, which is expected to be held in February, 2015. Mr. Sullivan currently serves as President, CEO and Director of Symmetry Medical Inc. (NYSE: SMA).
SMA: 9.27 (-0.04), SPAN: 18.30 (-0.15)
Symmetry Medical to Present at the Stifel 2014 Healthcare Conference
GlobeNewswire - Mon Nov 17, 8:29AM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that Thomas J. Sullivan, President and Chief Executive Officer, is scheduled to present at the Stifel 2014 Healthcare Conference in New York, NY.
SMA: 9.27 (-0.04)
Update: Symmetry Medical Posted Ordinary Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Sun Nov 09, 1:00AM CST
SMA: 9.27 (-0.04)
Symmetry Medical Q3 Earnings & Revenues Miss, Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:10PM CST
Symmetry Medical Inc. (SMA) reported adjusted earnings per share of 11 cents in the third quarter of fiscal 2014, which missed the Zacks Consensus Estimates of 14 cents.
SMA: 9.27 (-0.04), CYNO: 31.37 (+0.80), FLDM: 37.93 (-0.47), ANGO: 18.78 (+0.18)
Symmetry Medical Announces Mailing of Definitive Proxy Statement and Prospectus Related to Proposed Merger
GlobeNewswire - Wed Nov 05, 6:47AM CST
Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it is mailing the definitive proxy statement and prospectus regarding its agreement to sell its OEM Solutions business and concurrently transfer to its shareholders ownership in a new company holding its Symmetry Surgical business, Symmetry Surgical Inc. The Company will hold a special shareholder meeting on December 4, 2014, to approve the proposed transaction.
SMA: 9.27 (-0.04)
Symmetry Medical's (SMA) CEO Thomas Sullivan on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:50PM CDT
SMA: 9.27 (-0.04)
Symmetry Medical posts 3Q profit
Automated Insights - Thu Oct 30, 8:27AM CDT
WARSAW, Ind. (AP) _ Symmetry Medical Inc. (SMA) on Thursday reported profit of $1.3 million in its third quarter.
SMA: 9.27 (-0.04)
Symmetry Medical (SMA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:55AM CDT
SMA: 9.27 (-0.04)
Symmetry Medical misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:51AM CDT
SMA: 9.27 (-0.04)
Symmetry Medical Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Oct 30, 6:10AM CDT
Third Quarter Highlights:
SMA: 9.27 (-0.04)
Symmetry Medical Shares Up 12.9% Since SmarTrend's Buy Recommendation (SMA)
Comtex SmarTrend(R) - Wed Oct 29, 5:05PM CDT
SmarTrend identified an Uptrend for Symmetry Medical (NYSE:SMA) on May 29th, 2014 at $8.92. In approximately 5 months, Symmetry Medical has returned 12.89% as of today's recent price of $10.07.
SMA: 9.27 (-0.04)
